Project Orbis – New Regulatory Pathway for Innovative Oncology Therapies

Authors

  • Krisztina Gyimesi-Forrás G.L. Pharma GmbH. Arnethgasse 3., A-1160 Vienna, Austria

DOI:

https://doi.org/10.33892/aph.2021.91.228-229

Keywords:

Project Orbis, regulatory authority, oncology, FDA, CTD

Published

2021-11-15

How to Cite

(1)
Gyimesi-Forrás, K. Project Orbis – New Regulatory Pathway for Innovative Oncology Therapies . Acta Pharm Hung 2021, 91, 228-229.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License